AAJT-S Applications
THE ONLY ABDOMINAL TOURNIQUET. NO ALTERNATIVES. NO SUBSTITUTES.
The AAJT-S delivers what no other device can: true, non-invasive aortic control at the abdomen. Its abdominal application stops blood flow above the pelvis — controlling life-threatening abdominal, pelvic, and junctional hemorrhage.
Abdominal
Abdominal Stabilization Overview
When every second counts, the AAJT-S is the only abdominal and junctional tourniquet FDA-cleared to control bleeding in the abdomen—offering a vital bridge to definitive care in the face of catastrophic bleeding. Designed for speed, simplicity, and portability, the AAJT-S enables one-person application and effective control of life-threatening hemorrhage within seconds.
Why It Matters
Abdominal hemorrhage—especially from the abdominal aorta or solid organs like the liver or spleen—can lead to rapid exsanguination. Standard external compression is ineffective in these cases. The AAJT-S delivers targeted, internal vascular occlusion without the need for surgical access, making it an accessible REBOA alternative for austere, prehospital, and combat environments.
Contraindications: Known abdominal aortic aneurysm and pregnancy
APPLICATION TIME: UP TO 2 HOURS
Axilla
Axilla Stabilization Overview
Rapid Bleed Control in One of the Body’s Most Challenging Zones
Bleeding in the axilla—whether due to trauma, surgery, or penetrating injury—is notoriously difficult to manage. The axillary artery is a high-pressure vessel located in a tight anatomical space where traditional tourniquets are often ineffective.
The AAJT-S is FDA-cleared for use in the axilla, providing a powerful option to rapidly control bleeding when seconds matter. By compressing the subclavian artery against the mid clavicle, the device significantly reduces or stops blood flow to the site of injury.
APPLICATION TIME: UP TO 4 HOURS
Inguinal
Inguinal/Groin Stabilization Overview
Bleeding in the inguinal region, or groin, presents an immediate and life-threatening challenge in both civilian and combat trauma. The femoral artery—one of the body’s largest and most pressurized blood vessels—passes through this area. Injury to this artery, whether from penetrating trauma, blast injury, or pelvic fracture, can result in catastrophic hemorrhage and rapid exsanguination. Traditional tourniquets are ineffective in the groin due to the proximal location of the vessel and the anatomical complexity of the junctional zone.
The AAJT-S is cleared for the control of difficult-to-manage junctional hemorrhage, including the inguinal region. It is designed to compress the vessels running through the inguinal crease, between the groin and hip, rather than the thigh, where deeper vascular structures are located and bleeding is more difficult to access. This approach provides effective hemorrhage control in an area that is otherwise nearly impossible to manage with conventional means.
APPLICATION TIME: UP TO 4 HOUR
Pelvic Fracture
Pelvic Fracture Stabilization Overview
Pelvic fractures are a major cause of trauma-related mortality, with over 150,000 cases occurring annually in the U.S.—most commonly from motor vehicle collisions and high-impact trauma. Up to 40% of these patients die from hemorrhage associated with their injuries, often due to undetected internal bleeding within the pelvic cavity. Because pelvic fractures can damage multiple vascular structures, bleeding is frequently diffuse, non-compressible, and difficult to identify in the pre-hospital setting.
The AAJT-S is cleared for the control of pelvic bleeding and offers a critical intervention in these scenarios. By applying targeted compression over the lower abdomen and pelvis, the device reduces distal blood flow and tamponades bleeding vessels within the pelvic ring. This not only helps control hemorrhage but also stabilizes the pelvic structure, allowing for safer transport. In the absence of advanced imaging or surgical intervention, the AAJT-S serves as a vital bridge, giving patients the time they need to reach definitive care.
REBOA Trauma
REBOA Trauma Overview
The AAJT-S provides effective aortic compression at the point of injury and can be used as a bridge to REBOA when needed. It may remain inflated during femoral access and guidewire placement, allowing vascular teams to establish REBOA without compromising perfusion. Once REBOA is deployed, the AAJT-S can be deflated without loss of aortic control.
Military research has shown the AAJT-S produces a comparable “REBOA effect” within one minute of application, offering effective external aortic occlusion in pre-hospital and austere environments.
